FDA.reportPublic FDA data

allantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG Topical Ointment

RxCUI
1006096
RxNorm name
allantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG Topical Ointment
Display name
Allantoin/Benzocaine/Camphor/Petrolatum (Topical)
Full name
allantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG Topical Ointment
Term type
SCD
Status
Active
Strength
1-20-3-64.9%
Dose form
Ointment
Route
Topical
Updated
2026-06-05 07:03:41

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092010
Active start
092010
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
benzocaine0.2 MG / 1 MGbenzocainebenzocaine
camphor0.03 MG / 1 MGcamphorcamphor
allantoin0.01 MG / 1 MGallantoinallantoin
petrolatum0.649 MG / 1 MGpetrolatumpetrolatum

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Ointment316985

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
benzocaine1399
camphor1952
allantoin508
petrolatum8091

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRallantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG Topical OintmentNAMES
RxNorm Nameallantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG Topical OintmentNAMES
RxNorm Synonymallantoin 1 % / benzocaine 20 % / camphor 3 % / petrolatum, white 64.9 % Topical OintmentNAMES
TTYSCDATTRIBUTES
RxCUI1006096CODES

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
25bcfa70-64f9-18d6-51b0-83282c2f84beallantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG Topical OintmentSCD6Drug Facts20201125
25bcfa70-64f9-18d6-51b0-83282c2f84beallantoin 1 % / benzocaine 20 % / camphor 3 % / petrolatum 64.9 % Topical OintmentPSN6Drug Facts20201125
25bcfa70-64f9-18d6-51b0-83282c2f84beallantoin 1 % / benzocaine 20 % / camphor 3 % / petrolatum, white 64.9 % Topical OintmentSY6Drug Facts20201125

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04ABAnesthetics for topical useATC1-4benzocaine
ATCR02ADAnesthetics, localATC1-4benzocaine
ATCN01BAEsters of aminobenzoic acidATC1-4benzocaine
ATCC05ADLocal anestheticsATC1-4benzocaine
FDASPLN0000185508Standardized Chemical AllergenEPChas_epcbenzocaine
FDASPLN0000184306Cell-mediated ImmunityPEhas_pebenzocaine
FDASPLN0000175629Increased Histamine ReleasePEhas_pebenzocaine
MEDRTD000481AllantoinCHEMhas_ingredientallantoin
MEDRTD001566BenzocaineCHEMhas_ingredientbenzocaine
MEDRTD002164CamphorCHEMhas_ingredientcamphor
MEDRTD010577PetrolatumCHEMhas_ingredientpetrolatum
MEDRTD001424Bacterial InfectionsDISEASEci_withbenzocaine
MEDRTD002056BurnsDISEASEmay_treatbenzocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withcamphor
MEDRTD004433EaracheDISEASEmay_treatbenzocaine
MEDRTD005401Fissure in AnoDISEASEmay_treatbenzocaine
MEDRTD006484HemorrhoidsDISEASEmay_treatbenzocaine
MEDRTD006561Herpes SimplexDISEASEmay_treatbenzocaine
MEDRTD019226Oral UlcerDISEASEmay_treatbenzocaine
MEDRTD010032Otitis ExternaDISEASEmay_treatbenzocaine
MEDRTD010033Otitis MediaDISEASEmay_treatbenzocaine
MEDRTD010146PainDISEASEmay_preventbenzocaine
MEDRTD010146PainDISEASEmay_preventcamphor
MEDRTD010146PainDISEASEmay_treatcamphor
MEDRTD011537PruritusDISEASEmay_treatbenzocaine
MEDRTD012868Skin AbnormalitiesDISEASEmay_treatallantoin
MEDRTD014076Tooth DiseasesDISEASEmay_treatcamphor
MEDRTD014098ToothacheDISEASEmay_treatbenzocaine
MEDRTD014947Wounds and InjuriesDISEASEmay_treatallantoin
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moabenzocaine
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moacamphor
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pecamphor
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pebenzocaine
MEDRTN0000009735Decreased Skin KeratinizationPEhas_peallantoin

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.01 MG/MG / 0.2 MG/MG / 0.03 MG/MG / 0.649 MG/MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSCD
CODESRxCUI1006096
NAMESPrescribable Synonymallantoin 1 % / benzocaine 20 % / camphor 3 % / petrolatum 64.9 % Topical Ointment
NAMESRXNAV_STRallantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG Topical Ointment
NAMESRxNorm Nameallantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG Topical Ointment
NAMESRxNorm Synonymallantoin 1 % / benzocaine 20 % / camphor 3 % / petrolatum, white 64.9 % Topical Ointment
SOURCESSourceNational Drug Data File Plus Source Vocabulary